Hacker News new | ask | show | jobs
by MichaelGG 3713 days ago
Is he lying about doing drug research? He says no one else was doing anything for this disease as it is so rare. Seeing how old the drug is and no one else is even making it seems to prove that part of the claim.

Are there proofs of the availability program but working outside this video? Seems like news people should document such cases and bring them up. Even better if they'd do so live on his webcam.

2 comments

What he called drug research was in reality drug acquisition/market research. His spiel about his intention to do real research to improve abandoned drugs is intentionally unfalsifiable because it's about FUTURE research he promises to do, you know, some years down the road. We're supposed to take his word for it and meanwhile he makes his billions.

The reality is that all the executives at Turing were his hedge fund buddies, the investors were other hedge fund buddies and Shkreli made nearly a billion dollars in 3 years with his price-hiking shenanigans. In investor presentations he doesn't even refer to Turing as a pharma business nor does he talk about his planned pharmaceutical research, he presented the business as a pharma-hedgefund-hybrid: an easy way to make boatloads of money.

This isn't what you'd expect to see from somebody who is passionate about drug research and curing kids, this is what you expect to see from somebody who cynically exploits a system. That internal correspondence (again, subpoenaed) shows they're like "lol, sucker" whenever an individual pays the list price for their drugs makes it crystal clear how concerned they are about providing a service to humanity.

See e.g. http://democrats.oversight.house.gov/sites/democrats.oversig... for some nice quotes

> "Is he lying about doing drug research?"

I would say so, yes. Note how none of the products that they're supposedly developing are in clinical trials, despite being Turing Pharmaceuticals indicating they should be...

http://www.forbes.com/sites/johnlamattina/2015/12/15/martin-...